Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BuMA OCT Study(A Comparative Evaluation of BuMA Stent and of EXCEL Stent in Terms of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)

Trial Profile

BuMA OCT Study(A Comparative Evaluation of BuMA Stent and of EXCEL Stent in Terms of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Sirolimus (Primary) ; Antiplatelets
  • Indications Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders; Stent thrombosis; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms BuMA OCT
  • Sponsors SINO Medical Sciences Technology
  • Most Recent Events

    • 10 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 01 Nov 2013 Status changed from not yet recruiting to active, no longer recruiting as per results presented at the 25th Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
    • 21 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top